Article Detail - JE Part B
National Coverage Determination 200.3: Monoclonal Antibodies for the Treatment of Alzheimer’s Disease
Related CR Release Date: May 23, 2024
Effective Date: April 7, 2022
Implementation Date: June 24, 2024
MLN Matters Number: MM13598
Related Change Request (CR) Number: CR 13598
Related CR Transmittal Number: R12649CP
CR 13598 tells you about:
- FDA-approved monoclonal antibodies
- Criteria for coverage
- Coding information
- Claims processing instructions
Make sure your billing staff knows about these changes.
View the complete CMS Medicare Learning Network (MLN) Matters (MM)13598.